Reasons for rapid implementation of antenatal magnesium guidelines for neuroprotection

P. Middleton, C. Crowther, P. Ashwood, S. Reid, T. Bubner, E. Bain, E. Heatley, S. McIntyre, J. Morris & V. Flenady
Introduction: Within two years of dissemination of clinical practice guidelines, antenatal magnesium sulphate for protecting preterm babies’ brains is now given to 70-80% of eligible mothers giving birth in a number of Australian tertiary maternity hospitals in Australia, a fourfold increase.[for full text, please go to the a.m. URL]